Towards the Immunogenic Hyperthermic Action: Modulated ElectroHyperthermia

Author Info

Andras Szasz

Corresponding Author

Andras Szasz
Professor, Chair, Department of Biotechnics, St. Istvan University, Hungary

A B S T R A C T

Hyperthermia treatment for solid tumors is a long-used, but poorly accepted method in clinical use. Modulated electro-hyperthermia (mEHT, trade name: oncothermia®) changes the paradigm, introduces a novel, cellularly selective and immunogenic cell-ruination. The mEHT method produces tumor-vaccination, presenting the unharmed genetic information of cancer cells to immune cells [1]. The mEHT method is approved in more than 30 countries. Its phase II/III clinical applications indicate a broad perspective.

Article Info

Article Type

Research Article

Publication history

Received: Wed 19, Aug 2020
Accepted: Tue 08, Sep 2020
Published: Fri 18, Sep 2020

Copyright

© 2023 Andras Szasz. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2020.09.07